Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Elanco Animal Health Inc

NYSE: ELAN · Life Sciences · 3 alerts · CIK 1739104

Share price
$26.41Close, Nov 16
Market cap
$13.2B
Shares outstanding
499.83MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Elanco Animal Health Inc filings on SEC EDGAR ↗

9:11 AM ET 10-Q
Financial Results

Elanco Animal Health Q3 2026 Results: Turns Profitable, Net Income $18M

Elanco Animal Health reported revenue of $1,265 million for the third quarter of 2026, an increase from $1,137 million in the prior year. The company achieved a net income of $18 million for the quarter, recovering from a net loss of $34 million in Q3 2025, driven by higher gross profits and lower restructuring charges.

Key figure
Net income $18M
6:28 AM ET 8-K
Financial Results

Elanco Animal Health Financial Results

Elanco Animal Health reported Q3 2026 revenue of $1.265 billion, an 11% increase year-over-year, driven by strong demand for its 'Big 6' innovation products. The company raised its full-year 2026 guidance for revenue, Adjusted EBITDA, and Adjusted EPS while achieving a net leverage ratio milestone of 2.9x.

Term
Q3 2026

“Third quarter results demonstrate Elanco is a consistent, reliable growth company, delivering our diverse portfolio of innovation along with accelerating cash flow.”

Jeff Simmons, President and CEO of Elanco

“Organic constant currency revenue growth of 9% was led by International Pet Health up 17% and U.S. Pet Health up 13%, as we saw strong veterinarian and pet owner demand for what we believe is 'best medicine' innovation for our 'Big 6' growth led by Zenrelia and Credelio Quattro.”

Jeff Simmons, President and CEO of Elanco

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.